Page last updated: 2024-10-23

atenolol and Colorectal Cancer

atenolol has been researched along with Colorectal Cancer in 4 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Research Excerpts

ExcerptRelevanceReference
"Patients with a colorectal cancer- specific death (data from the Office of National Statistics death registration system) were matched to five controls."1.39β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort. ( Cardwell, CR; Hicks, BM; Hughes, CM; Murray, LJ; Powe, DG, 2013)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, Q1
Wang, F1
Yang, R1
Zheng, X1
Gao, H1
Zhang, P1
Hicks, BM1
Murray, LJ1
Powe, DG1
Hughes, CM1
Cardwell, CR1
Coelho, M1
Moz, M1
Correia, G1
Teixeira, A1
Medeiros, R1
Ribeiro, L1
Chin, CC1
Li, JM1
Lee, KF1
Huang, YC1
Wang, KC1
Lai, HC1
Cheng, CC1
Kuo, YH1
Shi, CS1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Perioperative β-adrenergic Blocker and a COX2 Inhibitor in Patients Undergoing Resection for Primary Colon and Rectal Cancer: Effect on Tumor Recurrence and Postoperative Immune Perturbations. A Multicenter Randomized Prospective Trial.[NCT00888797]Phase 3400 participants (Anticipated)Interventional2010-01-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

4 other studies available for atenolol and Colorectal Cancer

ArticleYear
Effect of chronic restraint stress on human colorectal carcinoma growth in mice.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Adrenergic Antagonists; Animals; Atenolol; Cell Proliferation; Colorectal Neoplasms; Epinephrine; Ge

2013
β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:12

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Case

2013
Antiproliferative effects of β-blockers on human colorectal cancer cells.
    Oncology reports, 2015, Volume: 33, Issue:5

    Topics: Adenocarcinoma; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Carbazoles; Carvedi

2015
Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
    Journal of cellular physiology, 2016, Volume: 231, Issue:2

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Animals; Apoptosis;

2016